Investigating the molecular drivers of high-level clinical responses to bimekizumab in psoriatic disease: Introducing the BE UNIQUE phase 3b study.

Authors

Johann E Gudjonsson, Joseph F Merola, Richard B Warren, Iain B McInnes, Balint Szilagyi, Christiane Simon-Hinsberg, Paul Jones, Joe Rastrick, Ann Cleverly, Ioana Cutcutache, James G Krueger

Published in

The Journal of investigative dermatology. Sep 01, 2026. Epub Sep 01, 2026.

PMID:
42678333
Bibliographic data and abstract were imported from PubMed on 01 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.